Subscribe to our Newsletters !!

    Kumar Jeetendra

    Jellagen dispatches JellaGel™, the principal Collagen Type 0 Hydrogel taking available driving Extracellular Matrix

    Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel. 3-dimensaional Hydrogels make it possible for cells to grow and interact with all of their surroundings that makes a massive difference. Cells grown in a 3D model have been shown to be more natural, with

    Researchers develop insect sex pheromones in transgenic camelina plant for maintainable pest control

    The camelina plant, a source of cooking oil for centuries, is on its way toward revolutionizing pest management in agriculture. Researchers at ISCA, Inc., a green agtech firm based in Riverside, Calif., and their collaborators in Sweden have “grown” insect sex pheromone precursors in genetically modified strains of camelina plants, creating a low-cost source of

    Strides Pharma Science arm gets USFDA gesture for HIV treatment drug

    Drug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has obtained approval from the US health regulator for Emtricitabine and Tenofovir Disoproxil Fumarate pills, used to treat HIV. The approved product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Truvada tablets of Gilead Sciences. Strides Pharma

    National consortium to examine the impacts of arising SARS-CoV-2 mutations

    The’G2P-UK’ National Virology Consortium will study how mutations in the virus affect key outcomes like how transmissible it is, the seriousness of COVID-19 it causes, and the potency of vaccines and treatments. The Consortium will bring together leading virologists from 10 research institutions. They will work together with the COVID-19 Genomics UK (COG-UK) consortium, which

    Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases

    Dundee, UK, 14th January 2021 – Ubiquigent Limited (Ubiquigent) and the Mottram Laboratory at the University of York today announced a collaboration to investigate the inhibition of deubiquitylase (DUB) enzymes expressed by the protozoan Leishmania mexicana for the treatment of leishmaniasis. The collaboration will be supported by a Global Challenges Research Fund grant, awarded by

    Waters APGC-MS/MS System Accepted for Advanced Dioxin and Furan Analysis Following USEPA Approval of SGS AXYS Method 16130

    Waters Corporation (NYSE:WAT) today announced that its Xevo TQ-XS atmospheric pressure gas chromatography (APGC) mass spectrometry (MS) platform is an accepted alternative for the identification and quantification of dioxins and furans in environmental samples. Dioxins are a byproduct of human industrial activity and their effects on human health are well documented1. The acceptance of Method

    Portuguese hospitals under stress as COVID-19 cases touched record

    Portugal’s fragile health system is under growing pressure because of worrying increase in coronavirus infections, with the nation reporting 10,947 new cases and 166 deaths on Saturday, the worst surge since the pandemic began last year. The cases, which come a day after a new lockdown was set in place, bring the whole number of

    Recently recognized supplement helps the gut review earlier diseases and execute attacking bacteria

    Scientists studying the body’s natural defenses against bacterial disease have identified a nutritional supplement –taurine–that helps the gut recall prior infections and kill invading bacteria, such as Klebsiella pneumoniae (Kpn). The finding, published in the journal Cell by scientists from five institutes of the National Institutes of Health, could help efforts seeking alternatives to antibiotics.